BlackBarn Capital Partners’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.8M Hold
1,585,000
3.44% 5
2026
Q1
$32.6M Buy
1,585,000
+285,000
+22% +$6.42M 2.62% 7
2025
Q4
$30.8M Buy
1,300,000
+209,618
+19% +$5.1M 2.03% 7
2025
Q3
$27.2M Buy
1,090,382
+340,382
+45% +$7.33M 1.94% 5
2025
Q2
$17.3M Hold
750,000
0.99% 11
2025
Q1
$16.8M Buy
750,000
+86,603
+13% +$2.01M 1.07% 9
2024
Q4
$13M Buy
663,397
+263,397
+66% +$5.22M 0.71% 12
2024
Q3
$7.28M Hold
400,000
0.96% 16
2024
Q2
$6.95M Buy
400,000
+200,000
+100% +$3.54M 0.62% 18
2024
Q1
$3.92M Buy
200,000
+65,000
+48% +$1.37M 2.21% 17
2023
Q4
$3.11M Buy
+135,000
New +$3.02M 1.12% 20

Other funds holding PRVA

BlackBarn Capital Partners's PRVA Position: Q2 2026 in Review

BlackBarn Capital Partners held its Privia Health (PRVA) position steady in Q2 2026 at 1,585,000 shares worth $40.8M. The position accounts for 3.44% of the portfolio, ranked #5.

BlackBarn Capital Partners first reported a position in PRVA in Q4 2023 and has held it in 11 quarters since. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • BlackBarn Capital Partners held 1,585,000 shares of Privia Health worth $40.8M as of Q2 2026.
  • BlackBarn Capital Partners left its Privia Health share count unchanged in Q2 2026.
  • Privia Health made up 3.44% of BlackBarn Capital Partners's portfolio in Q2 2026, its #5 holding.
  • BlackBarn Capital Partners first reported a position in Privia Health in Q4 2023 and has held it in 11 quarters since.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on BlackBarn Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.